Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$46.8 - $68.92 $340,095 - $500,841
-7,267 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$47.96 - $67.64 $1,966 - $2,773
41 Added 0.57%
7,267 $444,000
Q1 2020

May 13, 2020

BUY
$32.37 - $59.36 $6,797 - $12,465
210 Added 2.99%
7,226 $322,000
Q2 2019

Aug 07, 2019

SELL
$35.42 - $45.0 $99,813 - $126,810
-2,818 Reduced 28.66%
7,016 $316,000
Q1 2019

Apr 30, 2019

BUY
$28.09 - $39.49 $7,752 - $10,899
276 Added 2.89%
9,834 $370,000
Q4 2018

Feb 12, 2019

BUY
$29.83 - $46.51 $11,335 - $17,673
380 Added 4.14%
9,558 $328,000
Q3 2018

Nov 13, 2018

BUY
$33.9 - $47.77 $71,800 - $101,176
2,118 Added 30.0%
9,178 $431,000
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $181,442 - $338,032
7,060 New
7,060 $238,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.